We hypothesize that the lack of differences between patients with and without pulmonary fibrosis may be an effect of the influence of other factors like cytokines (tumor necrosis factor, IL-10), immunosuppressive therapy or the predominance of non-active SLE patients in the study. Here, IL10 is linked to systemic lupus erythematosus.